Serum citalopram and desmethylcitalopram concentrations in psychiatric patients;GITALOPRAM OG DESMETYLCITALOPRAM HOS PSYKIATRISKE PATIENTER

Ugeskrift for Laeger

Volumn 158, Issue 35, 1996, Pages 4920-4923

  Linnet, Kristian ^a   Olesen, Ole Vendelin ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CITALOPRAM; DRUG METABOLITE; ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MENTAL DISEASE; RANDOMIZED CONTROLLED TRIAL; ADOLESCENT; BLOOD; DEPRESSION; DRUG INTERACTION; MIDDLE AGED; PATIENT COMPLIANCE;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; CITALOPRAM; DEPRESSIVE DISORDER; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE;

EID: 0029665324     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Montgomery SA. Selecting the optimum therapeutic dose of serotonin reuptake inhibitors: studies with citalopram. Int Clin Psychopharmacol 1995: 10 (suppl 1): 23-7.
2. Danish University Antidepressant Group. Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Psychopharmacology 1986; 90: 131-8.
3. Geisler A, Arup P. Fluoxetin. Ugeskr Læger 1993; 155: 572-5.
4. Milne RJ, Goa KL. Citalopram - a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. Drugs 1991; 41: 450-77.
5. Gram LF. Fluoxetine. N Engl J Med 1994; 331: 1354-61.
6. Hyttel J. Citalopram - pharmacological profile of a specific serotonin uptake inhibitor with anodepressant activity. Prog Neuropsychopharmacol Biol Psychiatry 1982; 6: 277-95.
7. Song F, Freemantle N, Sheldon TA, House A, Watson P, Long A et al. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ 1993; 306: 683-7.
8. Olesen OV, Linnet K. A simplified HPLC method for determination of citalopram and desmethyl-citalopram in serum without interference from commonly used psychotropic drugs and their metabolites. J Chromatogr 1996; 675: 83-8.
9. Brøsen K, Kragh-Sørensen P. Concomitant intake of nortripty-line and carbamazepine. Ther Drug Monit 1993; 15: 258-60.
10. Jerling M, Bertilsson L, Sjoqvist F. The use of therapeutic drug monitoring data to document kinetic drug interactions: an example with amitriptyline and nortriptyline. Ther Drug Monit 1994; 16: 1-12.
11. Overø KF. Kinetics of citalopram in man; plasma levels in patients. Prog Neuropsychopharmacol Biol Psychiatry 1982; 6: 311-8.
12. Bjerkenstedt L, Flyckt L, Overe KF, Ungjaerde O. Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopram. A double-blind comparison of three dose levels. Eur J Clin Pharmacol 1985; 28: 533-7.
13. Gottlieb P, Wandall T, Overø KF. Initial, clinical trial of a new. specific 5-HT reuptake inhibitor, citalopram (Lu 10-171). Acta Psychiatr Scand 1980; 62: 236-44.
14. Pedersen OL, Kragh-Sørensen P, Bjerre M, Overø KF, Gram LF. Citalopram, a selective serotonin reuptake inhibitor: clinical antidepressive and long-term effect - a phase II study. Psychopharmacology 1982; 77: 199-204.
15. Dufour H, Bouchacourt M, Thermoz P, Viala A, Rop PP, Gouezo F et al. Citalopram - a highly selective 5-HT uptake inhibitor - in the treatment of depressed patients. Int Clin Psychopharmacol 1987; 2: 225-37.
16. Overø KF, Toft B, Christophersen L, Gylding-Sabroe JP. Kinetics of citalopram in elderly patients. Psychopharmacology 1985; 86: 253-7.
17. Brøsen K. Cytokrom P450 gen-superfamiliens betydning for Isegemidlers kliniske farmakokinetik. Ugeskr Læger 1991; 153: 417-22.
18. Sindrup SH, Brøsen K, Hansen MGJ, Aaes-Jørgensen T, Overø KF, Gram LF. Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms. Ther Drug Monit 1993; 15: 11-7.
19. Gram LF, Hansen MGJ, Sindrup SH, Brøsen K, Poulsen JH, Aaes-Jørgenen T et al. Citalopram: interaction studies with levomepromazine, imtpramine and lithium. Ther Drug Monit 1993; 15: 18-24.